Media & Press2019-09-17T16:08:49-04:00

    New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment

    April 12, 2021|

    Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because ... Read More

      Bexion Pharmaceuticals Announces the Addition of Olivia F. Kirtley to Board of Directors

      February 22, 2021|

      FOR IMMEDIATE RELEASE Covington, KY February 22, 2021 Bexion Pharmaceuticals, Inc. announced today that it has added Olivia F. Kirtley to its Board of Directors. Ms. Kirtley, a Certified Public Accountant and Chartered Global Management Accountant, is a business consultant on strategic, risk and corporate governance issues. She brings to Bexion extensive experience as ... Read More

        Bexion Pharmaceuticals Announces Database Lock in Phase 1 Trial of BXQ-350

        December 10, 2020|

        FOR IMMEDIATE RELEASE Covington, KY, December 10, 2020               Bexion Pharmaceuticals, Inc., a clinical stage biotech company focused on the discovery and development of life-changing treatments by leveraging the lysosome's roles in solid tumors and cell death with an initial focus on cancer, announced today the database lock for the Phase 1 study of BXQ-350 in adult patients ... Read More

        All Press